08:32 AM EDT, 03/20/2025 (MT Newswires) -- Knight Therapeutics ( KHTRF ) on Thursday reported a swing to fourth-quarter profit as revenue rose 31%.

The company reported net income was $10.7 million, compared with a loss of $24.3 million in the prior year period. Knight reported a net gain of $8.3 million helped by the revaluation of financial assets measured at fair value, versus a net loss of $7.9 million in the same period in prior year.

Revenue increased 31% to $97 million. Knight reported increased sales in all therapeutic areas.

For fiscal 2025, Knight expects to generate between $390 million to $405 million in revenue.